These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15725052)

  • 1. The Novolizer: a multidose dry powder inhaler: a viewpoint by Peter Haidl.
    Haidl P
    Treat Respir Med; 2005; 4(1):70. PubMed ID: 15725052
    [No Abstract]   [Full Text] [Related]  

  • 2. The Novolizer: a multidose dry powder inhaler: a viewpoint by Stephen P. Newman.
    Newman SP
    Treat Respir Med; 2005; 4(1):70. PubMed ID: 15725053
    [No Abstract]   [Full Text] [Related]  

  • 3. The Novolizer: a multidose dry powder inhaler.
    Siddiqui MA; Plosker GL
    Treat Respir Med; 2005; 4(1):63-9. PubMed ID: 15725051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novolizer: a multidose dry powder inhaler.
    Fenton C; Keating GM; Plosker GL
    Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy without success. Every 3d powder inhaler is used improperly (interview by Maria Weiss)].
    Wieshammer S
    MMW Fortschr Med; 2007 Nov; 149(48):8. PubMed ID: 18161431
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
    Fyrnys B; Stang N; Wolf-Heuss E
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.
    Prenner BM
    Expert Opin Pharmacother; 2007 Dec; 8(17):3069-84. PubMed ID: 18001266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic equivalence of the Sofotec Novolizer to established standard devices in COPD and asthma.
    Kunkel G; Chuchalin AG
    Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S15-7. PubMed ID: 11385811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in inhaler devices for asthma and COPD.
    Capriotti T
    Medsurg Nurs; 2005 Jun; 14(3):185-94. PubMed ID: 16035636
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Easyhaler--ideal dry powder inhaler].
    Andrzej E; Małgorzata BE
    Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved inhaler confirmed in general practice. Patients with respiratory diseases can breathe freely].
    MMW Fortschr Med; 2006 Dec; 148(49-50):52. PubMed ID: 17619331
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M; Leggett R; Pang C; Charles S; Gillett B; Prime D
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Great patient satisfaction with DuoResp Spiromax in routine inhalation therapy].
    Red
    MMW Fortschr Med; 2016 Feb; 158(3):66. PubMed ID: 27119706
    [No Abstract]   [Full Text] [Related]  

  • 17. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
    Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
    Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.